A Pilot Study to Evaluate Alternative Viral Load Tests During Start of Antiretroviral Therapy

NCT05418790 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-06-14

No results posted yet for this study

Summary

A pilot study of alternative viral load testing with samples collected in the clinic and at home compared to traditional viral load monitoring in participants engaged in HIV care. Approximately 15 participants starting ART, or working to suppress a detectable viral load, will monitor viral loads during regular clinic appointments and in intermediate time-points during their participation in this pilot study.

Conditions

Interventions

DEVICE

TASSO device

During this trial, participants will have approximately 15 TASSO collection dates between in clinic and at home.

Sponsors & Collaborators

Principal Investigators

  • Luis Montaner · The Wistar Institute

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-31
Primary Completion
2023-08-31
Completion
2023-09-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05418790 on ClinicalTrials.gov